Self-compassion and Mindfulness integrated online program for Living with Eczema - A randomize controlled trial (SMiLE Study)
Not Applicable
- Conditions
- atopic dermatitis
- Registration Number
- JPRN-UMIN000036277
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
Not provided
Exclusion Criteria
Either: 1) Under Dupixent treatment at enrollment or prior to 4-week follow-up assessment 2) Psychosis, personality disorder, PTSD, acute stress disorder or Developmental disability 3) Under mental health treatment for other diagnosis, and the therapist considers participation would be inappropriate 4) Under psychotherapy treatment at enrollment or prior to 4-week follow-up assessment 5) Have attended mindfulness or compassion programs, or will attend prior to 4-week follow-up assessment 6) Inability to understand Japanese 7) This study's researchers or their family members 8) Individuals whom researchers judge to inappropriate to participate in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease specific quality of life, DLQI-J. Outcomes will be measured at baseline, mid-term, post-intervention, 4-week follow-up, and 26-week follow-up (26-week is only for intervention group).
- Secondary Outcome Measures
Name Time Method Patient Oriented Eczema Measure (POEM), Itch related scales, Self-Compassion Scale (SCS-J), Freiburg Mindfulness Inventory, Hospital anxiety and depression scale(HADS) , Internalized Shame Scale, treatment adherence, home practice, and program feedback